Abstracts tagged "nutrition and rheumatoid arthritis (RA)"

Abstract Number: 127 • 2017 ACR/ARHP Annual Meeting
Diet Change and Omega-3 Supplementation in the First Three Years Following a Diagnosis with Rheumatoid Arthritis in Sweden
Maxine Lancelot^1,2, Olivier Grimaud³, Saedis Saevarsdottir⁴, Johan Askling⁵, Lars Klareskog⁶, Lars Alfredsson⁷ and Camilla Bengtsson⁸, ¹IMM, Karolinska Institutet, Stockholm, Sweden, ²EHESP, Paris, France, ³EHESP, Rennes, France, ⁴Rheumatology Unit, Department of Medicine, Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden, ⁵Unit of Clinical Epidemiology, Department of Medicine, Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden, ⁶Dept. of Medicine, Rheumatology Unit, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden, ⁷The Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden, ⁸Inst of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden
Background/Purpose: Major dietary modification and omega-3 supplements are often promoted on patient counseling websites for those with RA. Given uncertainty regarding such approaches, we aim…
Abstract Number: 2497 • 2016 ACR/ARHP Annual Meeting
Associations Between Dietary Intake of Vitamin D, Omega-3 Fatty Acids, Folate and EULAR Response in Patients with Early Rheumatoid Arthritis
Cecilia Lourdudoss¹, Alicja Wolk², Lena Nise³, Lars Alfredsson⁴ and Ronald F. van Vollenhoven¹, ¹Unit for Clinical Therapy Research, Inflammatory Diseases (ClinTRID), Dept. of Medicine, Karolinska institutet, Stockholm, Sweden, ²Unit of Nutritional Epidemiology, Dept of Environmental Medicine, Karolinska institutet, Stockholm, Sweden, ³Unit of Cardiovascular Epidemiology, Dept of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden, ⁴Section of Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden
Background/Purpose: We hypothesized that increased dietary intake of vitamin D and omega-3 fatty acids (FA) prior to disease modifying anti-rheumatic drug (DMARD) initiation may associate…
Abstract Number: 1463 • 2013 ACR/ARHP Annual Meeting
Dietary Impact On Treatment Results Of Methotrexate In Patients With Rheumatoid Arthritis
Cecilia Lourdudoss¹, Alicja Wolk², Camilla Bengtsson³, Lena Nise⁴, Lars Alfredsson³ and Ronald van Vollenhoven⁵, ¹Unit for Clinical Therapy Research, Inflammatory Diseases (ClinTRID), Karolinska institutet, Stockholm, Sweden, ²Institute of Environmental Medicine (IMM), Karolinska institutet, Stockholm, Sweden, ³Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden, ⁴Institute of Environmental Medicine, Karolinska institutet, Stockholm, Sweden, ⁵Unit for Clinical Research Therapy. Inflammatory Diseases (ClinTrid), Karolinska Institute, Stockholm, Sweden
Background/Purpose: Some specific diets have been shown to ameliorate rheumatoid arthritis (RA). However, there is generally a lack of studies on any possible dietary impact…
Abstract Number: 2692 • 2012 ACR/ARHP Annual Meeting
Diet and Other Lifestyle Related Factors and the Risk of Developing Rheumatoid Arthritis
Björn Sundström¹, Ingegerd Johansson² and Solbritt Rantapää Dahlqvist³, ¹Department of Public Health & Clinical Medicine, Rheumatology, Umeå University, Umeå, Sweden, ²Department of Odontology, Cariology, Umeå Universitet, Umeå, Sweden, ³Department of Public Health and Clinical Medicine/Rheumatology, Umeå University Hospital, Umeå, Sweden
Background/Purpose: There is a growing interest in the role of lifestyle in developing chronic diseases, such as rheumatoid arthritis (RA). Our aim was to investigate…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].